BioMelbourne Network
Progressing BioIndustry

• Home
• About Us
• Events
• Grants & Awards
• News & Opinion
• Membership
• Resource Library
• Contact

27 September 2011, Melbourne, Australia and Basel, Switzerland 26 September 2011 - Global regenerative medicine company Mesoblast Limited (ASX: MSB) and Lonza Group (SWS: LONN), a world leader in biologic manufacturing, today announced that they have entered into a strategic alliance for clinical and long-term commercial production of Mesoblast’s off-the-shelf (allogeneic) adult stem cell produ... read more…

26 September 2011. Melbourne, Australia : Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) has today announced the appointment of Ms Zita Peach as a Non-Executive Director.   Zita has more than 20 years of commercial experience in the pharmaceutical industry, particularly in marketing and business development, working for major industry players such as CSL Limited and Merck Sharp & Dohm... read more…

  19 September 2011, Melbourne, Australia: Australian drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) has, in collaboration with 3M, completed the optimisation of the TPM/oxycodone patch. This milestone clears the way for the company to commence its pivotal oxycodone clinical trials. Phosphagenics has previously shown that the prototype patches developed in-... read more…

  14 September 2011, Melbourne, Australia: Melbourne drug delivery technology company Phosphagenics Limited (ASX: POH) has entered into an agreement with a leading global cosmetic and dermatology company to conduct a human study on a new cosmetic product incorporating its TPM® platform delivery system. Phosphagenics’ CEO, Dr Esra Ogru, said the partnership with another leading cosmetic, hig... read more…

4 September 2011Clinuvel says it has completed its pre-clinical program for its ultra-violet light protection drug Scenesse or afamelanotide.Clinuvel said completing the program was “an important regulatory milestone” for filing the marketing authorization application to the European Medicines Agency for the orphan disease erythropoietic protoporphyria.The company said the data from the four pr... read more…

4 September 2011Acrux says co-founder Prof Barrie Finnin has retired as a director after 12 years’ service to the company. Acrux said Prof Finnin was a co-inventor of its transdermal drug delivery technology and he played an integral role in developing the core technology and the company’s corporate growth. Acrux said it would appoint a suitably qualified non-executive director to replace Pro... read more…

Friday, 2 September 2011. Information sessions, held across Australia in September and October, will help businesses learn how to access and best use the new R&D Tax Incentive to drive the development of new ideas, products and processes. Encouraging people to attend, Innovation Minister Senator Kim Carr, said the R&D Tax Incentive, as the program will be now known, will support and reward the... read more…

31st August, 2011 - Medicines Development is pleased to announce that Charlotte Mulder has completed its rigorous Development Manager Training Program and has been successfully placed at Virax Holdings Ltd as a Development Manager. Charlotte is Medicines Development's first trainee and placement under its Development Manager training and placement initiative supported by the Victorian Governmen... read more…

24th August 2011 - The Gillard Labor Government’s new R&D Tax Credit will help businesses in every sector of the Australian economy transform and invest in the future – leading to more high-wage, high-skill jobs. The Credit, which passed the Parliament today, is a key element of the Government’s innovation agenda, Powering Ideas, a comprehensive program to transform and secure a future for Aus... read more…

23 August 2011 - The research and development reforms passed in the Parliament today increase support for small and medium sized businesses, particularly after the Greens secured amendments to help the cash-flow of these companies which are the engine room of innovation in Australia.The agreement to make quarterly cash payments to small and medium-sized companies, instead of annual tax credits,... read more…